Fundraising Fox

Anne Grahl

Investor

Analyst at Pureos Bioventures

Switzerland

Writes $100K – $5M checks · typically $1.5M

About

Anne Grahl is an Investment Manager at Pureos Bioventures with a background in biochemistry, structural biology, and biophysics. She works at the intersection of science and venture capital within the biotech sector.

Experience

  1. Pureos BioventuresInvestment Managercurrent2025 — present
  2. Pureos BioventuresAssociate2023 — 2025Switzerland
  3. Pureos BioventuresAnalyst2021 — 2023Switzerland
  4. PulseSight TherapeuticsBoard Membercurrent2025 — present
  5. Mediar TherapeuticsBoard Observercurrent2023 — present
  6. YVC CollectiveBoard Membercurrent2023 — present
  7. M VenturesInvestment Analyst2021Amsterdam Area
  8. i&i PragueCollaborator2020 — 2021
  9. Biozentrum, University of BaselPostdoctoral Researcher2019 — 2021
  10. Biozentrum, University of BaselPhD Student2014 — 2018

Education

  1. Biozentrum, University of BaselDoctor of Philosophy - PhD, Structural Biology2014 — 2018
  2. European Summer SchoolEntrepreneurship and New Venture Creation2020
  3. Kiel UniversityMaster of Science - MS, Biochemistry and Molecular Biology2011 — 2013
  4. University of YorkErasmus program, Biochemistry2010 — 2011
  5. Friedrich Schiller University JenaBachelor of Science - BS, Biochemistry and Molecular Biology2008 — 2011

Skills & more

Public SpeakingAnalytic Problem Solving1TeamworkInvestments1Project Leadership1Portfolio ManagementMembrane Proteins1BiophysicsBiochemistryScientific WritingTime Management1Molecular & Cellular Biology1
+5 moreResearchProject ManagementComputational BiologyStructural BiologyCorporate Venture Capital

Languages English · German

From Anne's professional profile.

Same school

Shared employers

Colleagues at Pureos Bioventures

Network5

Investors connected to Anne in public investor directories — a warm-intro map.